Preparing patients with immune thrombocytopenia for surgery: what are the options?

Affiliations

¹ Weill Cornell Medicine, New York, NY, USA. Electronic address: jbussel@med.cornell.edu.
² Section of Hematology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Comment

James B Bussel et al. Lancet Haematol. 2020 Sep.

. 2020 Sep;7(9):e626-e627.

doi: 10.1016/S2352-3026(20)30253-2.

¹ Weill Cornell Medicine, New York, NY, USA. Electronic address: jbussel@med.cornell.edu.
² Section of Hematology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

No abstract available

Comment on

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial.
Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG. Arnold DM, et al. Lancet Haematol. 2020 Sep;7(9):e640-e648. doi: 10.1016/S2352-3026(20)30227-1. Lancet Haematol. 2020. PMID: 32853584 Clinical Trial.